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Abstract
Background: Multiple primary cancers have a low incidence particularly when cancers are synchronous. Few cases
of synchronous head and neck cancer and breast carcinoma are reported in the literature.
Case presentation: We report here an exceptional case of a 47 years old Moroccan woman presenting two
synchronous cancers, the first in the nasopharynx and the second in the breast. The patient was treated
successfully with a combined strategy associating chemotherapy, radiation therapy, and surgery. She remains
disease free after 27 months of follow up.
Conclusions: Treatment strategy in the case of multiple primary cancers remains controversial because of the
variety of presentations; initial aggressive treatment reports good results.
Background
The incidence of multiple primary cancers (MPC) is
estimated between 0,73% and 11,7% [1]. The association
of different cancers is classified in two categories
depending on the timing of their discovery; synchronous
in which the cancers occur at the same time or within
two months, as the case that we report, or metachro-
nous in which the cancers follow in sequence of more
than two months apart [2].
The undifferentiated carcinoma of the nasopharynx is
a common cancer in North Africa and in the Mediterra-
nean basin, but the incidence of a double malignancy
including a nasopharyngeal carcinoma is very uncom-
mon. We report here a case of an undifferentiated naso-
pharyngeal carcinoma with a synchronous breast cancer
treated successfully with induction chemotherapy
followed by local control of both tumours.
Case presentation
A 47 years old Moroccan woman with a familial history
of a father dead from a colorectal cancer, and a mater-
nal aunt dead from a breast cancer, presented to our
institute with complaints of nasal obstruction, headache,
and ear fullness for three months, and skin changes on
the right breast for two months. She did not breastfeed
her four children, had a regular menstrual cycle, and
took oral contraception.
On physical examination, the right breast had a 6 × 5 cm
lump on retroareolar area fixed to the skin with thicken-
ing of the whole breast and nipple retraction. The axillae
and the cervical regions were free of any adenopathy.
Mammogram showed an increase in density on the right
breast with abnormal skin thickening in the periareolar
area and associated microcalcifications (Figure 1), the
complement of ultrasound revealed a nodular lesion
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ogy there were signs of malignancy confirmed with core
biopsy of the lump suggesting a ductal infiltrating carci-
noma with micropapillary component (Figure 2).
At presentation our patient had developed a unilateral
conductive hearing loss associated with recurrent otitis
media and numbness of the face. A computed tomogra-
phy (CT) of the face and the skull showed an asymmetric
mass in the posterior nasopharynx extended into the
adjacent parapharyngeal spaces and infiltrating the sphe-
noid bone, no regional adenopathies were revealed, and
the nasopharyngeal biopsy confirmed the diagnosis of an
undifferentiated nasopharyngeal carcinoma (Figure 3).
There were no distant metastases and we conclude the
diagnosis of a locally advanced breast cancer with a syn-
chronous stage III undifferentiated nasopharyngeal
carcinoma.
The patient received induction chemotherapy combi-
nation of drugs sharing an activity on breast and naso-
pharyngeal carcinomas, association of taxanes and
anthracyclines drugs was used (weekly Paclitaxel 80 mg/
m
2 for 12 weeks associated to Doxorubicine 50 mg/m
2
every 3 weeks) for a total of 4 cycles. The treatment was
generally well tolerated; the patient had 3 episodes of
grade III-IV non febrile neutropenia, grade II mucositis,
total alopecia, and grade II neuropathy reversible after
several months thereafter. After the four cycles of che-
motherapy there were a remarkable improvement on
the breast and a relief in the symptoms of the nasophar-
yngeal tumour.
The induction therapy was followed by external beam
radiation for the nasopharynx (70Gy in 35 fractions)
with concurrent chemotherapy (weekly Cisplatine 40
mg/m2 for four weeks) and a prophylactic radiation to
cervical lymph nodes. Evolution was marked by the
improvement of the symptoms and a radiological reduc-
tion volume of the nasopharyngeal mucosa thickening
which biopsy confirmed the absence of malignancy. This
sequelar lesion has persisted until the last control with-
out trend to progression.
Breast intervention was delayed until after the local
control of the nasopharyngeal tumour. A right-sided
modified radical mastectomy with axillary nodes dissec-
tion was carried out. Histological analysis of the mas-
tectomy specimen revealed a 2 mm residual infiltrating
ductal carcinoma grade II, neither insitu component nor
lymphovascular emboli were found, hormonal receptors
were positives (90% on estrogens receptor, and 30% on
progesterone receptor), Her2 status was negative, and
from the 11 lymph nodes dissected 4 were involved.
Surgery was followed by chest wall irradiation, and the
patient undergoes now an antihormonal therapy; she
has accomplished 12 months of Tamoxifene. The latest
medical controls show no signs of locoregional relapse
for both tumours and our patient remains disease-free
27 months after beginning therapy.
Figure 1 Breast mammogram. Right breast mammogram showing an increase in density on the right breast with abnormal skin thickening in
the periareolar area and associated microcalcifications.
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T h ep r e s e n c eo fm u l t i p l es y n c h r o n o u st u m o u r si nt h e
head and neck area and the upper aerodgestive tract is
well established [3,4], this association has been explained
by the concept of “field cancerization”[5]. In a Chinese
analysis 3% of patient with nasopharyngeal carcinoma
develop a second cancer, most common site are the
aerodigestive tract, lymphoproliferative malignancies,
skin, and connective tissue. The risk of developing a sec-
ond breast cancer was estimated to 1,34 [6].
Sel’chuk et al in 100 patients with head and neck can-
cers found a rate of 19% of synchronous tumours
detected on the breast [7]. Strobel et al in a systematic
detection of synchronous primaries to squamous head
and neck carcinomas on 589 patients found one case of
breast second cancer [8]. Driss et al have reported a
case of breast metastases from an undifferentiated
nasopharyngeal carcinoma, in the English literature
there is only three well documented cases of this setting
[9]. The association that we report here includes two
primary sites from different histological types.
A retrospective study by Di Martino et al concerning
the survival in second primary malignancies of patients
with head and neck cancers conclude that the prognosis
of synchronous tumours is significantly lower when
compared to malignancies of a metachronous nature,
results report 26% of 5 year overall survival for meta-
chronous setting after the occurrence of the second can-
cer, and 11,9% for the synchronous setting (p < 0,0001),
a second interesting conclusion from this study is that
only the early implementation of aggressive treatment
methods for second primaries is successful in terms of
survival [10]. In our case we have opted for this aggres-
sive strategy and treated our patient with combined
Figure 2 Histopathology of the breast lesion. Photomicrograph of the histopathological analysis of the breast biopsy showing an infiltrating
ductal carcinoma grade II.
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on the breast and nasopharyngeal cancers followed by
local control therapy of both tumours. Results were
encouraging with a survival exceeding two years and
without local or distant relapse.
The distinctive racial/ethnic and geographic distribu-
tion of NPC worldwide suggests that both environmental
factors and genetic traits contribute to its development,
well-established risk factors for NPC include elevated
antibody titers against the Epstein-Barr virus (EBV), con-
sumption of salt-preserved fish, a family history of NPC,
and certain human leukocyte antigen class I genotypes
[11]. In another hand, an association between two pri-
maries suggests common ethological risk factors.
Positive association between alcohol intake and carci-
noma of the breast has been consistently demonstrated
[12]. In the case of the nasopharyngeal carcinoma a sys-
tematic review by Chen et al suggests that heavy alcohol
consumption is associated with an increased risk of
NPC [13]. Our patient had no history of alcohol intake.
Besides of the exogenous risk factors, Bongers et al
suggest that an intrinsic susceptibility may influence the
risk for the development of second primary tumours in
patients with head and neck carcinoma [14], the familial
h i s t o r yo fc a n c e ri nt h ec a s et h a tw er e p o r tm i g h t
invoke the genetic susceptibility in the pathogenesis of
this association of primaries and the hereditary predis-
position to multiple cancers.
Other explanation could be the role of EBV which impli-
cation is well established like etiological factor of NPC,
furthermore, a recent study by Mazouni et al provides evi-
dence for EBV-associated breast cancer undergoing dis-
tinct carcinogenic processes with more aggressive features
[15]. At last, this unusual association of breast cancer and
NPC would be due to a chance phenomenon.
Synchronous double malignancy of head and neck and
breast is very uncommon, etiology remains obscure,
there is no standard approach for the treatment strategy,
and in our case treating both malignancies with the
same induction chemotherapy combination followed by
local therapy was successful.
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Figure 3 Histopathology of the nasopharyngeal lesion. Photomicrograph of the histopathological analysis of the nasopharynx biopsy
showing the aspect of an undifferentiated carcinoma.
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